The VGH-based team of medical experts that make up the Leukemia/Bone Marrow Transplant Program of BC provide the specialized care and treatment required by their patients. Each year in BC, approximately 2,000 new cases of blood diseases including leukemia and myeloma are diagnosed in adults.

Significant progress is being made in the battle against blood disease. Vancouver is at the forefront of many of these advancements. The Hematology Division at VGH is one of the most comprehensive and well-regarded programs in North America, providing the highest standard of care to patients across British Columbia and leading innovative, cutting-edge research.

The Program's research component – the Hematology Research Clinical Trials Unit (HRCTU) – provides the scientists and medical experts pursuing blood disease research with the support they need to develop and test new treatment options for patients. Through HRCTU clinical trials, hundreds of blood disease patients in British Columbia get access to new, improved, and potentially life-saving treatment options that would otherwise be unavailable to them.

Support from donors has a direct impact on the lives of patients and families affected by blood cancers by enhancing the care the Hematology team is able to provide to patients and the research they are able to conduct. A gift from you could help improve the quality and quantity of treatment options available for adults confronted with a blood disease diagnosis.